Professor Steven Tong
Honorary fellow
Qualifications:
PhD, Charles Darwin University, 2010; Bachelor of Medicine and Bachelor of Surgery with Honours, University of Melbourne, 1998; Fellow Royal Australasian College of Physicians, 2006; Graduate Diploma Clinical Epidemiology, Newcastle University, 2010.
Approved level of HDR supervision at Charles Darwin University:
Associate Supervisor for PhD
Location:
Biography:
Professor Tong is an infectious diseases physician with research interests in infectious diseases affecting Indigenous people. He aims to combine clinical epidemiology with molecular genetic approaches to better understand the patterns and transmission of diseases due to agents such as Staphylococcus aureus, hepatitis B, and influenza.
He was the inaugural Northern Territory Fulbright Scholar and trained at Duke University, North Carolina in 2011. He was also a visiting scientist at the Wellcome Trust Sanger Institute for all of 2012.
He has established numerous collaborations with overseas laboratories as well as fellow clinician-researchers in Australia. He is currently co-leading an international multicentre randomised controlled trial of combination therapy for S. aureus bloodstream infections.
Prof Tong is affiliated with Menzies, the Victorian Infectious Disease Service, The Royal Melbourne Hospital, and the Doherty Department, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity
- Bowen, A.C., Harris, T., Holt, D.C., Giffard, P.M., Carapetis, J.R., Campbell, P.T., McVernon, J., & Tong, S.Y.C. (2016). Whole genome sequencing reveals extensive community-level transmission of group A Streptococcus in remote communities. Epidemiology Infections, 144, 1991-8.
- Andersson, P., Harris, S.R., Seth-Smtih, H.M.B., Hadfield, J., O’Neill, C., Cutcliffe, L.T., et al. (2016). Chlamydia trachomatis isolates from Australian Aboriginal people with trachoma form distinct lineages. Nature Communications, 7,10688.
- Clemens, E.B., Grant, E.J., Wang, Z., Gras, S., Tipping, P., Rossjohn, J.,et al. (2016). Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians. Immunology Cell Biology, 94, 367-77.
- Davis, J.S, Sud, A., O’Sullivan, M.V.N., Robinson, J.O., Ferguson, P.E., Foo, H., et al. (2016). Combination of vancomycin and β-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: A pilot multicenter randomized controlled trial. Clinical Infectious Diseases, 62, 173-80.
- Tong, S.Y.C., Davis, J.S., Eichenberger, E., Holland, T.,& Fowler, V.G. (2015). Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clinical Microbiology Reviews, 28, 603-61.
- Tong, S.Y.C., Holden, M.T.G., Nickerson, E.K., Cooper, B.S., Köser, C.U., Cori, A., et al. (2015). Genome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureus in a high transmission setting. Genome Research, 25,111–8.
- Tong, S.Y.C., Schaumburg, F., Ellington, M.J., Corander, J., Pichon, B., Leendertz, F., et al. (2015). Novel staphylococcal species that form part of a Staphylococcus aureus related complex: the non-pigmented S. argenteus sp. nov. and the non-human primate associated S. schweitzeri sp. nov. International Journal of Systematic and Evolutionary Microbiology, 65, 15-22.
- Bowen, A.C., Tong, S.Y.C., Andrews, R.M., O'Meara, I.M., McDonald, M.I., Chatfield, M.D., Currie, B.J., & Carapetis, J.R. (2014). Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet, 384, 2132-40.
- Davies, J., Littlejohn, M., Locarnini, S.A., Whiting, S., Hajkowicz, K., Cowie, B.C., Bowden, D.S., Tong, S.Y., & Davis, J.S. (2013). .The molecular epidemiology of hepatitis B in the Indigenous people of northern Australia. Journal of Gastroenterology and Hepatology Foundation, 28, 1234-41.
- Flint, S.M., Davis, J.S., Su, J.-Y., Oliver-Landry, E.P., Rogers, B.A., Goldstein, A., et al. (2010). Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia’s Northern Territory. Medical Journal of Australia, 192, 1-6.
